RegulatoryOfficial

FDA publishes Q&A guidance on transferring a 510(k) clearance between holders

🇺🇸 FDA CBER · Thu 19 Nov 2026

The document addresses common questions on selling or transferring a 510(k), including when a new holder need not file a fresh submission and when the original submission number must be used.

The US Food and Drug Administration has published a question-and-answer guidance on the transfer or sale of a premarket notification (510(k)) clearance from one holder to another. The page is dated 19 November 2026 and filed under docket number FDA-2024-D-1528. It lists biologics and medical devices as regulated products, and names the Center for Devices and Radiological Health as the issuing office.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA CBER ↗

Article written by VigiEye from the official source (FDA CBER). AI-assisted; check the source before acting.